ClinConnect ClinConnect Logo
Search / Trial NCT02352103

Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery

Launched by HENRY FORD HEALTH SYSTEM · Jan 27, 2015

Trial Information

Current as of July 03, 2025

Completed

Keywords

Prostate Cancer Urinary Continence Robotic Assisted Radical Prostatectomy Vattikuti Urology Institute (Vip) Radical Prostatectomy Retzius Sparing Radical Prostatectomy

ClinConnect Summary

Traditionally, RARP is performed using a trans-peritoneal technique that pass anteriorly to the bladder. This technique necessitates the dissection and/or manipulation of many structures, which might compromise post-operative urinary continence recovery. These structures include the pubo-prostatic ligament, Santorini plexus, neurovascular bundle, and veil of Aphrodite. Recently, a "Retzius-sparing" technique to perform RARP has beed described. This approach passes posteriorly to the bladder, through the space of Douglas, which should minimize the damaged to the aforementioned structure. The...

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • All patients with newly diagnosed prostate cancer undergoing robotic-assisted radical prostatectomy at the Vattikuti Urology Institute (performed by single surgeon, MM) as the primary treatment modality
  • Be able to read and speak English and be able to provide written informed consent
  • Exclusion Criteria:
  • patients with high risk prostate cancer,defined as a biopsy Gleason score ≥8 and/or a pre-operative prostate specific antigen value ≥20 ng/ml.
  • evidence of clinical nodal involvement (cN1) or metastatic disease (M1)
  • patients participating in a competing study
  • patients with pre-operative urinary incontinence.

About Henry Ford Health System

Henry Ford Health System is a comprehensive, nonprofit healthcare organization based in Detroit, Michigan, renowned for its commitment to advancing medical research and patient care. With a robust network of hospitals, outpatient facilities, and specialty clinics, Henry Ford Health System is dedicated to innovation in clinical trials, focusing on translating scientific discoveries into effective treatments. The organization emphasizes multidisciplinary collaboration, leveraging its extensive resources and expertise to address diverse health challenges. Through its clinical research initiatives, Henry Ford Health System aims to enhance patient outcomes and contribute to the advancement of medical knowledge on both a local and global scale.

Locations

Detroit, Michigan, United States

West Bloomfield, Michigan, United States

Patients applied

0 patients applied

Trial Officials

Mani Menon, MD

Principal Investigator

Henry Ford Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials